货号 | MAB890-SP |
别名 | APP 695+1 | 全称 | Amyloid Precursor Protein 695+1 Frameshift Mutant |
反应种属 | Human |
应用 | Western Blot,Immunoprecipitation |
目标/特异性 | Detects human APP695+1 in Western blots. It recognizes a common epitope present on APP695+1 and APP770 found within the segments L18-R288 or P365-R411 of APP770 (Accession # P05067). |
使用方法 | Western Blot: 1 µg/mL Immunoprecipitation: 25 µg/mL |
来源 | Reconstitute at 0.5 mg/mL in sterile PBS. |
产品组分 |
供应商 | R&D Systems |
Entrez Gene IDs | 351 (Human); 11820 (Mouse) |
纯化方式 | Protein A or G purified from hybridoma culture supernatant |
免疫原 | S. frugiperda insect ovarian cell line Sf 21-derived recombinant human APP695+1 frameshift mutant Leu18-Arg336 (predicted) Accession # NP_958817 |
生物活性 | Human |
标记 | Unconjugated |
溶解方法 | Reconstitute at 0.5 mg/mL in sterile PBS. |
背景 | Amyloid precursor protein (APP) is a type I membrane protein with several human isoforms due to alternative splicing. APP770, 751, and 733 contain a Kunitz protease inhibitor (KPI) domain (residue 291‑342) and APP695 does not. APP is a cell surface molecule with many functions. It can be processed proteolytically in two different pathways. In one pathway, beta - and gamma -secretase cleave at the beta site between residue 670 and 671 and the gamma site between residue 711 and 714 to produce beta ‑amyloid peptide (A beta 40 and A beta 42), a major component in plaques found in brains of patients with Alzheimers disease (1). The other pathway involves alpha -secretase that cleaves residues between 687 and 688. It is antiamyloidogenic due to its benign character and the prevention of the A beta peptide formation (2). Soluble APP containing the KPI domain, also referred to as protease nexin II, is a potent inhibitor of serine proteases and may have additional functions. For example, it may regulate the contact face of blood coagulation and limit thrombosis specially in brain due to its localization and coagulation factor XI inhibiting activity (3, 4). |
运输条件 | Blue Ice |
存放说明 | 4℃ |
参考文献 |
|